Literature DB >> 1922806

Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency.

S P Stabler1, R H Allen, R E Barrett, D G Savage, J Lindenbaum.   

Abstract

We measured methylmalonic acid, which accumulates in the blood and tissues of patients with cobalamin deficiency, in the CSF of 65 patients using capillary-gas chromatography and mass spectrometry. In 58 control patients, methylmalonic acid concentrations were always higher in CSF than in serum (mean CSF: serum ratio, 2.65; range, 1.17 to 7.78). In contrast, in six patients with elevated serum methylmalonic acid levels due to renal failure, CSF concentrations were normal in five and the CSF: serum ratio was less than one in four. In three patients with neuropsychiatric syndromes due to cobalamin deficiency and one patient with a normal serum cobalamin level who was an abuser of nitrous oxide, CSF concentrations were markedly increased (mean level, 600 times that of controls), out of proportion to those in the serum (mean CSF: serum ratio, 8.38; range, 3.5 to 13.5). The potential usefulness of CSF metabolite levels in the diagnosis of cobalamin deficiency is undetermined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922806     DOI: 10.1212/wnl.41.10.1627

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  A detailed analysis of methylmalonic acid kinetics during hemodialysis and after combined liver/kidney transplantation in a patient with mut (0) methylmalonic acidemia.

Authors:  Hilary J Vernon; C John Sperati; Joshua D King; Andrea Poretti; Neil R Miller; Jennifer L Sloan; Andrew M Cameron; Donna Myers; Charles P Venditti; David Valle
Journal:  J Inherit Metab Dis       Date:  2014-06-25       Impact factor: 4.982

2.  Cerebrospinal fluid homocysteine and the cobalamin status of the brain.

Authors:  H J Blom; R A Wevers; A Verrips; M T TePoele-Pothoff; J M Trijbels
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Methylmalonic acid induces inflammatory response and redox homeostasis disruption in C6 astroglial cells: potential glioprotective roles of melatonin and resveratrol.

Authors:  Rômulo Rodrigo de Souza Almeida; Larissa Daniele Bobermin; Belisa Parmeggiani; Krista Minéia Wartchow; Diogo Onofre Souza; Carlos-Alberto Gonçalves; Moacir Wajner; Guilhian Leipnitz; André Quincozes-Santos
Journal:  Amino Acids       Date:  2022-08-04       Impact factor: 3.789

Review 4.  Physiology and pathophysiology of organic acids in cerebrospinal fluid.

Authors:  G F Hoffmann; W Meier-Augenstein; S Stöckler; R Surtees; D Rating; W L Nyhan
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 5.  Neurological manifestations of organic acid disorders.

Authors:  G F Hoffmann; K M Gibson; F K Trefz; W L Nyhan; H J Bremer; D Rating
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

6.  Growth retardation, general hypotonia, and loss of acquired neuromotor skills in the infants of mothers with cobalamin deficiency and the possible role of succinyl-CoA and glycine in the pathogenesis.

Authors:  Zafer Bicakci
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

7.  Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression.

Authors:  Chadwick W Christine; Peggy Auinger; Nasrin Saleh; Miao Tian; Teodoro Bottiglieri; Erland Arning; Nam K Tran; Per Magne Ueland; Ralph Green
Journal:  Mov Disord       Date:  2020-05-14       Impact factor: 10.338

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.